Burford Capital Logo Light Burford Capital Logo Dark

Burford's Joshua Harris quoted on patents in Reuters

  • Patent & IP
November 22, 2022

Reuters reports on how generic drugmakers Teva and Sandoz are making a major push to biosimilars, quoting Burford's Joshua Harris as an expert on the subject.

Harris, a Senior Vice President with expertise in pharmaceutical patents, said that "'Creating the only biosimilar in a particular market for a particular drug could be a win," while also adding that it would be "a rare situation."

Click here to view full article.